Home›Stock Screener›Amanta Healthcare

Amanta Healthcare Share Price Today | Stock Price & Amanta Healthcare Share Screener

AMANTA Pharmaceuticals & Biotechnology
Live Share Price NSE
₹239.08
▲ 1.70 (0.72%)
2026-11-19 00:00:00
Live Share Price BSE
₹238.95
▲ 2.20 (0.93%)
2026-11-19 00:00:00

As of November 19, 2026, the live Amanta Healthcare share price (NSE: AMANTA) is ₹239.08 on NSE and ₹238.95 on BSE, up 0.72% from the previous close, with shares trading between ₹232.41 and ₹241.77 in today's trading session, and a 52-week range of ₹95.03–₹239.08. Track AMANTA company valuation to gauge the company's total market size. Use the Amanta Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amanta Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹307 and net income of ₹18, with EBITDA of ₹66, an operating margin of 21.0% and a profit margin of 5.9%.

Amanta Healthcare Market Cap ₹910.59 Cr.
AMANTA P/E Ratio (TTM) 46.70
Amanta Healthcare P/B Ratio 3.75
EPS (TTM) ₹4.33
Dividend Yield -
Debt to Equity 1.33
AMANTA 52 Week High ₹239.08
Amanta Healthcare 52 Week Low ₹95.03
Operating Margin 21.00%
Profit Margin 5.86%
AMANTA Revenue (TTM) ₹307.00
EBITDA ₹66.00
Net Income ₹18.00
Total Assets ₹558.00
Total Equity ₹220.00

Amanta Healthcare Share Price Chart

Track the current stock price of Amanta Healthcare with an interactive chart. Analyse AMANTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amanta Healthcare stock quote in one place.

The quote of ₹239.08 sits between the 52-week low of ₹95.03 and the 52-week high of ₹239.08, and the latest session moved 0.72% from the previous close.

Amanta Healthcare Company Profile - Fundamental Screener

Screen Amanta Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMANTA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE084K01015.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE084K01015

Amanta Healthcare Balance Sheet Screener

Screen AMANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹558, up from ₹382 in 2025.

Latest statistics put total assets at ₹558 and shareholder funds at ₹220, with a leverage ratio of 1.33.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 558 382 352 374 392 392 388
Current Assets 0 0 0 0 0 0 0
Fixed Assets 207 217 228 232 240 242 244

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 197 170 184 214 214 262 285
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 220 96 66 63 72 7 29
Share Capital 39 29 27 27 37 27 27
Reserves & Surplus 181 68 40 36 36 -20 2

Amanta Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Amanta Healthcare income statement and profit fundamentals. Analyze AMANTA quarterly results. Amanta Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹307 and net profit was ₹18, equal to earnings per unit of ₹5.10, at an operating margin of 21%.

In that period expenses were ₹241, interest cost ₹21 and tax ₹6. The next period listed, 2026-March, shows revenue of ₹291 and net profit of ₹15.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Revenue and Expenses

Revenue 307 291 276 282 263 227 172 187
Expenses 241 228 215 223 206 173 133 147

Operating Costs and Margins

EBITDA 66 63 61 59 56 54 39 40
Operating Profit % 21.00% 21.00% 22.00% 21.00% 20.00% 23.00% 22.00% 20.00%
Depreciation 20 19 18 20 18 17 17 17
Interest 21 21 28 34 35 49 40 38

Profit and Earnings

Profit Before Tax 25 21 15 5 3 62 -18 -15
Tax 6 6 4 2 5 7 4 4
Net Profit 18 15 11 4 -2 55 -22 -19
EPS 5.10 4.33 3.71 1.35 -0.79 20.54 -8.14 -7.04

Amanta Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen AMANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹49, and net cash flow was an inflow of ₹81.

Over the same period, investing activities used ₹94 and financing activities provided ₹126.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 49 47 58 43 62 31 38
Investing Activities -94 -25 -10 -7 -6 -13 -9

Financing and Net Cash

Financing Activities 126 -24 -46 -42 -50 -18 -37
Net Cash Flow 81 -1 1 -6 6 0 -8

Amanta Healthcare Shareholding Pattern Screener

See Amanta Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Amanta Healthcare promoter holding and ownership changes for AMANTA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 63.72%, foreign institutions 0.85%, domestic institutions 12.88% and the public 16.00%, spread across 15,222 shareholders.

The shareholder count was 15,222 in 2026-Mar, compared with 12,612 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Feb 2025-Jun 2025-Aug 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 63.72% 63.80% 63.80% 85.52% 63.56% 85.60% 63.56% 63.56%

Institutional Investors

FII Holding 0.85% 0.43% 0.07% 0.00% 2.21% 0.00% 1.00% 1.10%
DII Holding 12.88% 12.92% 12.20% 0.00% 12.22% 0.00% 11.34% 11.24%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 16.00% 17.45% 18.31% 0.00% 20.28% 0.00% 17.35% 16.91%
Other Holding 6.56% 5.39% 5.62% 14.48% 1.74% 14.40% 6.75% 7.19%
Shareholder Count 15,222 12,612 12,319 200 30,695 361 360 16,181

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amanta Healthcare. Amanta Healthcare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Amanta Healthcare.

Amanta Healthcare Stock Index Membership - Nifty & Sensex

See which indices include Amanta Healthcare stock. Check AMANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Amanta Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Amanta Healthcare Market Events Screener - Corporate Actions

Get Amanta Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amanta Healthcare stock events that may affect AMANTA share price, along with derivatives, futures and options activity and sector gainers.

7 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Annual General Meeting dated September 16, 2026 and Quarterly Result Announcement dated August 5, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-03 2026-11-03 Quarterly Result Announcement NA 0.14%
2026-09-16 2026-09-16 Annual General Meeting NA 13.97%
2026-08-05 2026-08-05 Quarterly Result Announcement NA 6.95%
2026-05-19 2026-05-19 Quarterly Result Announcement NA -9.66%
2026-02-10 2026-02-10 Quarterly Result Announcement NA 1.14%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -1.63%
2025-09-26 2025-09-26 Quarterly Result Announcement NA -0.50%

Amanta Healthcare Competitors Screener - Peer Stocks Comparison

Screen AMANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,676 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,997 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,586 85.00 13,886 20.34% 2,138 47.23
Laurus Labs 126,325 89.90 6,868 22.01% 890 57.04
Zydus Life Science 120,119 27.60 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 115,854 41.80 35,059 3.90% 4,158 71.26
Cipla 112,131 39.50 29,045 2.24% 3,870 53.06
Mankind Pharma 107,805 47.90 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,229 25.80 34,145 5.56% 3,503 60.39
Lupin 89,172 17.30 29,039 26.75% 5,356 39.39

Amanta Healthcare Company Announcements - News & Reports Screener

Screen AMANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 16, 2026 and November 12, 2026.

Date Update Actions
2026-11-17 Company Response On The Spurt In Volume Of Security Across Exchanges -
2026-11-16 Clarification sought from Amanta Healthcare Ltd -
2026-11-12 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-12 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-11-10 Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 (The Insider Trading Regulations) -
2026-11-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-04 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-04 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-04 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-03 Statement Of Deviation Or Variation In Utilization Of Funds If Any Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations") -
2026-11-03 To Approve Unaudited Financial Results For Quarter And Half Year Ended September 30 2026 -
2026-11-03 Board Meeting Outcome for To Approve Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2026 -
2026-11-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-30 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-26 Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-10-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-05 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-10-01 Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 - Off Market Transfer Of Equity Shares -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹239.08, within a 52-week range of ₹95.03 to ₹239.08. The P/E ratio is 46.70 and the P/B ratio is 3.75, with earnings per unit of ₹4.33. Market capitalisation stands at ₹910.59 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.